SIGMA Members

The SIGMA Consortium is formed by a group of leading research institutions and Universities with extensive expertise and experience in the conduct of pharmacoepidemiologic and real-world evidence research:

Country InstitutionLead
Denmark Aarhus University, Department of Clinical Epidemiology
Prof. Vera Ehrenstein
(SIGMA Executive Committee member)
Denmark University of Southern Denmark, Department of Clinical Pharmacology and Pharmacy
Prof. Jesper Hallas, FISPE
FranceUniversity of Bordeaux’s Bordeaux PharmacoEpi Platform
Dr. Cecilé Droz
GermanyLeibniz-Institut für Präventionsforschung und Epidemiologie – BIPS GmbH
Prof. Ulrike Haug
ItalyAgenzia Regionale di Sanità (ARS Toscana)
Dr. Rosa Gini
Netherlands PHARMO Institute for Drug Outcomes Research
Prof. Ron Herings, FISPE
(SIGMA Executive Committee member)
NetherlandsUniversity Medical Centre Utrecht (UMCU)
Prof. Miriam Sturkenboom, FISPE
NetherlandsUtrecht University Division of Pharmacoepidemiology & Clinical Pharmacology
Prof. Olaf Klungel
SpainFundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
Dr. Maria Giner
Spain/USARTI Health Solutions
Dr. Susana Perez-Gutthann, FISPE
(SIGMA Executive Committee member, Board Chair)
United KingdomUniversity of Dundee
Prof. Thomas MacDonald, FISPE

The SIGMA consortium collaborates with the following research institutions:

SwedenKarolinska InstituteProf. Helle Kieler
ItalyUniversity of Verona
Dr. Gianluca Trifiró
Prof. Giampiero Mazzaglia